| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial
|
Ortiz-Romero, Pablo L
|
|
|
9 |
6 |
p. e425-e433
|
artikel
|
| 2 |
A curious case of a neutrophilic horn
|
Benoit, Tobias M
|
|
|
9 |
6 |
p. e460
|
artikel
|
| 3 |
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
|
Dimopoulos, Meletios A
|
|
|
9 |
6 |
p. e403-e414
|
artikel
|
| 4 |
Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study
|
Pemmaraju, Naveen
|
|
|
9 |
6 |
p. e434-e444
|
artikel
|
| 5 |
An integrated approach to cardioprotection in lymphomas
|
Maraldo, Maja V
|
|
|
9 |
6 |
p. e445-e454
|
artikel
|
| 6 |
Bedside art is good medicine
|
Gore, Emily
|
|
|
9 |
6 |
p. e401-e402
|
artikel
|
| 7 |
Correction to Lancet Haematol 2022; 9: e361–73
|
|
|
|
9 |
6 |
p. e398
|
artikel
|
| 8 |
Elotuzumab: no benefit for older patients with newly diagnosed multiple myeloma
|
Touzeau, Cyrille
|
|
|
9 |
6 |
p. e386-e387
|
artikel
|
| 9 |
Future role of topical pimecrolimus in early stage mycosis fungoides?
|
Scarisbrick, Julia Jane
|
|
|
9 |
6 |
p. e389-e391
|
artikel
|
| 10 |
Improving outcomes through patient-generated evidence—the next step in patient advocacy
|
Geissler, Jan
|
|
|
9 |
6 |
p. e399-e400
|
artikel
|
| 11 |
Making a case for disease-modifying agents in myelofibrosis
|
Maffioli, Margherita
|
|
|
9 |
6 |
p. e391-e392
|
artikel
|
| 12 |
Prehospital blood transfusion for haemorrhagic shock
|
Simpson, John T
|
|
|
9 |
6 |
p. e396-e397
|
artikel
|
| 13 |
Prehospital blood transfusion for haemorrhagic shock
|
Cardinale, Michael
|
|
|
9 |
6 |
p. e395
|
artikel
|
| 14 |
Prehospital blood transfusion for haemorrhagic shock
|
del Junco, Deborah J
|
|
|
9 |
6 |
p. e395-e396
|
artikel
|
| 15 |
Prehospital blood transfusion for haemorrhagic shock – Authors' reply
|
Crombie, Nick
|
|
|
9 |
6 |
p. e397
|
artikel
|
| 16 |
Sex and gender reporting in high impact haematology journals
|
Jacobs, Jeremy W
|
|
|
9 |
6 |
p. e392-e394
|
artikel
|
| 17 |
Sickle cell disease: a year in review
|
The Lancet Haematology,
|
|
|
9 |
6 |
p. e385
|
artikel
|
| 18 |
The case for classical haematology: the impact of a name and the future of a field
|
Al-Samkari, Hanny
|
|
|
9 |
6 |
p. e455-e459
|
artikel
|
| 19 |
Venetoclax and acute myeloid leukaemia: an expanding new frontier
|
Sahasrabudhe, Kieran D
|
|
|
9 |
6 |
p. e387-e389
|
artikel
|
| 20 |
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
|
Wang, Huafeng
|
|
|
9 |
6 |
p. e415-e424
|
artikel
|
Tijdschrift beschrijving